Aveanna Healthcare Announces Successful Debt Refinancing

Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) announced the successful closing of a refinanced first lien credit facility, as disclosed on September 18, 2025. This significant move involves refinancing an existing $886.0 million principal balance of first lien term loans and borrowing an additional $439.0 million in incremental first lien term loans. The refinancing also increases the company's revolving credit facility from $170.3 million to $250.0 million in maximum availability. Notably, the maturity dates for the combined $1.325 billion in first lien term loans have been extended to 2032, while the revolving credit facility’s maturity has been pushed back from 2028 to 2030.

The use of proceeds from the incremental loans has allowed Aveanna to fully repay its $415.0 million second lien term loans, resulting in the termination of the second lien facility. This refinancing was carried out with Barclays Bank PLC and Jefferies Finance LLC serving as co-lead arrangers.

Matt Buckhalter, Chief Financial Officer, emphasized that this refinancing represents a crucial step in enhancing the company's balance sheet, extending maturities, and increasing liquidity. Concurrently, CEO Jeff Shaner acknowledged the support of their capital partners and highlighted how the refinancing reflects Aveanna's strong operational performance and the intrinsic value of its national home care platform.

Headquartered in Atlanta, Georgia, Aveanna Healthcare operates across 38 states, providing a comprehensive range of pediatric and adult healthcare services, including nursing, rehabilitation, home health, hospice services, and case management. The company focuses on delivering high-quality, cost-effective alternatives to prolonged hospitalization. For further information, visit www.aveanna.com.

Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) recently announced a successful debt refinancing that significantly enhances the company's financial position. With the closure of an $886 million refinancing on existing first lien credit, along with an additional $439 million in incremental loans, Aveanna is poised for robust operational momentum. The company has extended the maturity dates of its loans to 2032 and increased its revolving credit facility from $170.3 million to $250 million, which are strategic moves designed to bolster liquidity and strengthen its balance sheet.

From a market perspective, this refinancing is a positive signal for investors. It indicates confidence from capital partners and the ability of Aveanna's management to navigate its financial obligations effectively. By paying off its second lien term loans of $415 million and terminating that facility, Aveanna has streamlined its debt, which should reduce interest expenses and improve cash flows.

Investors should consider that a sound balance sheet and increased liquidity typically lead to enhanced growth prospects. The healthcare services sector, particularly in home care, is witnessing increased demand as populations age and seek more accessible healthcare solutions. Aveanna’s diverse range of services targeting both pediatric and adult patients positions it well to capitalize on these trends.

While the refinancing enhances Aveanna's growth strategy, investors should also evaluate potential risks such as market competition, regulatory pressures, and the overall economic environment affecting healthcare spending. As Aveanna continues to execute its expansion plans and leverage its national platform, there may be an opportunity for investors to capitalize on potential share price appreciation.

In conclusion, Aveanna's recent refinancing is a substantial development that strengthens its financial foundation. Investors should monitor its execution of growth strategy while keeping an eye on broader market conditions.